Neurofilament light-chain response during therapy with antisense oligonucleotide tofersen in SOD1-related ALS: Treatment experience in clinical practice

Meyer, T; Schumann, P; Weydt, P; Petri, S; Koc, Y; Spittel, S; Bernsen, S; Günther, R; Weishaupt, JH; Dreger, M; Kolzarek, F; Kettemann, D; Norden, J; Boentert, M; Vidovic, M; Meisel, C; Münch, C; Maier, A; Körtvélyessy, P

Meyer, T (通讯作者)，Charite Univ Med Berlin, Ctr ALS & Other Motor Neuron Disorders, Dept Neurol, Augustenburger Pl 1, D-13353 Berlin, Germany.

MUSCLE & NERVE, 2023; 67 (6): 515

Abstract

Introduction/AimsIn amyotrophic lateral sclerosis (ALS) caused by superoxide dismutase 1 (SOD1) gene mutations (SOD1-ALS), the antisense oligonucleoti......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索